Pregnant Women's Access to PMTCT and ART Services in South Africa and Implications for Universal Antiretroviral Treatment
Pregnant Women's Access to PMTCT and ART Services in South Africa and Implications for Universal Antiretroviral Treatment
复制标题
DOI：
10.1371/journal.pone.0027907
复制
发表时间：
2011-12-05
期刊：
影响因子：
3.7
通讯作者：
Esterhuizen, Tonya M.
中科院分区：
文献类型：
--
作者：
Hussain, Akthar;Moodley, Dhayendre;Esterhuizen, Tonya M.
目的：我们描述了孕妇获得PMTCT和HAART服务和相关的出生outcomes in South Africa.Methods：妇女在产后病房的转诊医院休养参加了一项评估在2010年2月至5月期间，他们的产妇记录进行了检查，以描述他们获得VCT，CD 4计数，双重ART或HAART在怀孕期间。在1609名参与这项评估的妇女中，39%（95%CI 36.7 -41.5%）在怀孕期间检测出HIV阳性。在艾滋病毒呈阳性的妇女中，2.9%没有进行CD 4计数，另外31.3%没有收到其CD 4结果。大多数（96.8%）艾滋病毒阳性妇女在第一次产前检查时开始接受双重抗逆转录病毒治疗，与其CD 4结果无关。在2010年2月至5月期间，48.0%具有CD 4结果的妇女有资格接受HAART（CD 4
Objectives: We describe pregnant womens' access to PMTCT and HAART services and associated birth outcomes in South Africa.Methods: Women recuperating in postnatal wards of a referral hospital participated in an evaluation during February-May 2010 during which their maternity records were examined to describe their access to VCT, CD4 Counts, dual ART or HAART during pregnancy.Results: Of the 1609 women who participated in this evaluation, 39% (95%CI36.7-41.5%) tested HIV-positive during their pregnancy. Of the HIV-positive women 2.9% did not have a CD4 count done and an additional 31.3% did not receive their CD4 results. The majority (96.8%) of the HIV-positive women commenced dual ART at their first antenatal visit independent of their CD4 result. During February-May 2010, 48.0% of the women who had a CD4 result were eligible for HAART (CD4